peer reviewedInfrainguinal arterial occlusive disease is very common at the age of 60 years or older. It remains often asymptomatic. In one third of cases, it results in claudication. Claudication is a benign symptom that rarely necessitates surgery or endovascular intervention. Physical training and control of risk factors are sufficient in most cases to improve the walking performance. Nowadays, the authors do no longer perform femoropopliteal bypass grafting as a first choice treatment for intermittent claudication. Conservative treatment has gained widespread acceptance for infrainguinal atherosclerosis with moderate ischemia. What is the fate of the claudicant? How effective is exercise therapy? Should we broaden the indications for pe...
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing ...
Introduction: Infrainguinal arterial occlusive disease can lead to claudication, as well as to chron...
Today the problem about the best way to manage peripheral arterial disease (PAD) remains unresolved....
peer reviewedInfrainguinal arterial occlusive disease is very common at the age of 60 years or older...
Endovascular therapy has become an accepted mode of therapy for lifestyle-limiting claudication, esp...
BackgroundPercutaneous transluminal angioplasty ± stent (PTA/S) and surgical bypass are both accepte...
In patients with intermittent claudication and long chronic total occlusions of the superficial femo...
ObjectiveTo determine the preferred approach to superficial femoral artery (SFA) revascularization o...
Objectives: Although international guidelines state that supervised exercise therapy (SET) should be...
AbstractObjectivesAlthough international guidelines state that supervised exercise therapy (SET) sho...
Background: Since the introduction of femorofemoral crossover bypass by Freeman and Leeds in 1952 (C...
AbstractAim. To evaluate whether angioplasty or above-knee bypass is the best treatment for symptoma...
The prevalence of intermittent claudication is around 4.5% in general population aged between 55 to ...
Introduction: Often physicians and patients believe that occluded vessels could not be recanalized b...
BackgroundFirst-line treatment for patients with superficial femoral arterial (SFA) occlusive diseas...
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing ...
Introduction: Infrainguinal arterial occlusive disease can lead to claudication, as well as to chron...
Today the problem about the best way to manage peripheral arterial disease (PAD) remains unresolved....
peer reviewedInfrainguinal arterial occlusive disease is very common at the age of 60 years or older...
Endovascular therapy has become an accepted mode of therapy for lifestyle-limiting claudication, esp...
BackgroundPercutaneous transluminal angioplasty ± stent (PTA/S) and surgical bypass are both accepte...
In patients with intermittent claudication and long chronic total occlusions of the superficial femo...
ObjectiveTo determine the preferred approach to superficial femoral artery (SFA) revascularization o...
Objectives: Although international guidelines state that supervised exercise therapy (SET) should be...
AbstractObjectivesAlthough international guidelines state that supervised exercise therapy (SET) sho...
Background: Since the introduction of femorofemoral crossover bypass by Freeman and Leeds in 1952 (C...
AbstractAim. To evaluate whether angioplasty or above-knee bypass is the best treatment for symptoma...
The prevalence of intermittent claudication is around 4.5% in general population aged between 55 to ...
Introduction: Often physicians and patients believe that occluded vessels could not be recanalized b...
BackgroundFirst-line treatment for patients with superficial femoral arterial (SFA) occlusive diseas...
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing ...
Introduction: Infrainguinal arterial occlusive disease can lead to claudication, as well as to chron...
Today the problem about the best way to manage peripheral arterial disease (PAD) remains unresolved....